免疫疗法
癌症免疫疗法
肿瘤微环境
免疫系统
癌症疫苗
癌症研究
癌症
医学
免疫学
内科学
作者
Qiankun Ni,Fengfei Xu,Yufei Wang,Yujie Li,Guangchao Qing,Yuxuan Zhang,Jie Zhong,Jinghong Li,Xing‐Jie Liang
标识
DOI:10.1016/j.jconrel.2022.01.003
摘要
The past decade has witnessed a great progress in cancer immunotherapy with the sequential approvals of therapeutic cancer vaccine, immune checkpoint inhibitor and chimeric antigen receptor (CAR) T cell therapy. However, some hurdles still remain to the wide implementation of cancer immunotherapy, including low immune response, complex tumor heterogeneity, off-target immunotoxicity, poor solid tumor infiltration, and immune evasion-induced treatment tolerance. Owing to changeable physicochemical properties in response to endogenous or exogenous stimuli, nanomaterials hold the remarkable potential in incorporation of multiple agents, efficient biological barrier penetration, precise immunomodulator delivery, and controllable content release for boosting cancer immunotherapy. Herein, we review the recent advances in nanomaterials with changeable physicochemical property (NCPP) to develop cancer vaccine, remold tumor microenvironment and evoke direct T cell activation. Besides, we provide our outlook on this emerging field at the intersection of NCPP design and cancer immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI